HomepageLH • NYSE
add
LabCorp
Vorige slotkoers
$Â 238,73
Jaar-range
$Â 191,97 - $Â 247,99
Beurswaarde
19,83Â mld. USD
Gem. volume
723,64K
Koers/winst
46,26
Dividendrendement
1,21%
Primaire beurs
NYSE
In het nieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
(USD) | sep 2024info | Wijziging j-o-j |
---|---|---|
Opbrengst | 3,28Â mld. | 7,37% |
Bedrijfskosten | 632,30Â mln. | 8,79% |
Netto inkomsten | 169,30Â mln. | -7,64% |
Netto winstmarge | 5,16 | -14,00% |
Winst per aandeel | 3,50 | 3,55% |
EBITDA | 433,60Â mln. | 4,26% |
Effectief belastingtarief | 19,47% | — |
Balans
Totale activa
Totale passiva
(USD) | sep 2024info | Wijziging j-o-j |
---|---|---|
Contanten en kortetermijnbeleggingen | 1,52Â mld. | 108,45% |
Totale activa | 18,61Â mld. | 10,22% |
Totale passiva | 10,43Â mld. | 15,94% |
Totaal aandelenvermogen | 8,19 mld. | — |
Uitstaande aandelen | 83,64 mln. | — |
Koers-boekwaardeverhouding | 2,45 | — |
Rendement op activa | 3,85% | — |
Rendement op kapitaal | 4,53% | — |
Kasstroom
Nettomutatie in liquide middelen
(USD) | sep 2024info | Wijziging j-o-j |
---|---|---|
Netto inkomsten | 169,30Â mln. | -7,64% |
Operationele kasstroom | 277,30Â mln. | -27,96% |
Kasstroom uit beleggingen | -579,10Â mln. | -18,77% |
Kasstroom uit financiering | 1,55Â mld. | 241,11% |
Nettomutatie in liquide middelen | 1,25Â mld. | 204,12% |
Vrije kasstroom | 62,96Â mln. | -61,33% |
Over
Laboratory Corporation of America Holdings, headquartered in Burlington, North Carolina, provides laboratory services used for diagnosis and healthcare decisions. It operates one of the largest clinical laboratory networks in the world and has operations in over 100 countries; although its operations are primarily in the U.S.
Its Diagnostics Laboratories segment operates 2,000 patient service centers with more than 6,000 in-office phlebotomists in the United States. In addition to healthcare testing such as oncology testing, human immunodeficiency virus genotyping and phenotyping, it provides testing for: employment, DNA testing to determine parentage and to determine immigration eligibility, environmental issues, wellness, toxicology, pain management, and medical drug monitoring. It also provides 50 tests that patients can complete at home. It processes over 160 million tests per year. Approximately 10% of the division's revenue are from Medicare.
Its Biopharma Laboratory Services segment provides drug development, medical device and diagnostic development services to pharmaceutical, biotechnology, medical device, and diagnostic companies. Wikipedia
Opgericht
1978
Hoofdvestiging
Website
Werknemers
61.975